Extended Data Table 1 Correlations between T2*values and laboratory iron markers, hepcidin and hsCRP

From: Empagliflozin effects on iron metabolism as a possible mechanism for improved clinical outcomes in non-diabetic patients with systolic heart failure

  1. In the absence of significant treatment group-specific correlations, all correlations (P values) are reported across both treatment arms.
Back to article page